Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 20/20 | 0.48 |
| ▸ | BTK | Q06187 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29208847 | 0.92 | EGFR (0.51) | EGFRBTK | |
| SCHEMBL23759824 | 0.88 | EGFR (0.59) | EGFRBTK | |
| SCHEMBL23759756 | 0.87 | EGFR (0.58) | EGFRBTK | |
| SCHEMBL23759661 | 0.85 | EGFR (0.63) | EGFR | |
| SCHEMBL23759752 | 0.85 | EGFR (0.52) | EGFRBTK | |
| SCHEMBL22951346 | 0.85 | EGFR (0.55) | EGFRBTK | |
| SCHEMBL29857374 | 0.85 | EGFR (0.55) | EGFRBTK | |
| SCHEMBL23759814 | 0.85 | EGFR (0.52) | EGFRBTK | |
| SCHEMBL23759767 | 0.84 | EGFR (0.59) | EGFR | |
| SCHEMBL22950964 | 0.84 | EGFR (0.52) | EGFRBTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114885607-B | Quinolinylphosphine oxide compounds, compositions and uses thereof | 贝达药业股份有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-114885607-A | Quinolylphosphine oxygen compounds, compositions and uses thereof | 贝达药业股份有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-114885607-B | Quinolinylphosphine oxide compounds, compositions and uses thereof | 贝达药业股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-114885607-A | Quinolylphosphine oxygen compounds, compositions and uses thereof | 贝达药业股份有限公司 | 2022-08-09 | — | — | CN | disclosed |